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ABSTRACT  
 
Glomerulosa cells secrete aldosterone in response to agonists coupled to Ca2+ increases such as 
angiotensin II and corticotrophin, coupled to a cAMP dependent pathway. A recently recognized 
interaction between Ca2+ and cAMP is the Ca2+ - induced cAMP formation in the mitochondrial 
matrix. Here we describe that soluble adenylyl cyclase (sAC) is expressed in H295R 
adrenocortical cells. Mitochondrial cAMP formation, monitored with a mitochondria-targeted 
fluorescent sensor (4mtH30), is enhanced by HCO3
- and the Ca2+ mobilizing agonist angiotensin 
II. The effect of angiotensin II is inhibited by 2-OHE, an inhibitor of sAC, and by RNA 
interference of sAC, but enhanced by an inhibitor of phosphodiesterase PDE2A. Heterologous 
expression of the Ca2+ binding protein S100G within the mitochondrial matrix attenuates 
angiotensin II–induced mitochondrial cAMP formation. Inhibition and knockdown of sAC 
significantly reduce angiotensin II – induced aldosterone production. These data provide the first 
evidence for a cell-specific functional role of mitochondrial cAMP.  
 
 
1. Introduction 
 
Cyclic AMP and Ca2+, the two most common second messengers in eukaryotic cells, control a 
variety of cellular functions as diverse as secretion, contraction, cell movement and death. These 
two messengers may act synergistically, as observed e.g. in cardiac myocytes, whereas their 
action may be antagonistic in other tissues, as in smooth muscle cells (Bolton et al., 1999; Schaub 
and Kunz, 1986; Sperelakis, 1990). In aldosterone-producing adrenal glomerulosa cells 
angiotensin II and extracellular K+ concentration control aldosterone secretion via Ca2+ signaling 
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whereas the action of corticotrophin (ACTH) is mediated by cAMP (Spät and Hunyady, 2004). 
Under acute stimulatory conditions the site of action is, in both cases, the Steroidogenic Acute 
Regulatory Protein (StAR) that facilitates the cholesterol transport to the cholesterol side chain 
cleaving enzyme (cytochrome P450scc), located on the inner mitochondrial membrane (reviewed 
in (Hattangady et al., 2011; Spät and Hunyady, 2004)). Calcium ions exert intramitochondrial 
action(s) as well. By activating mitochondrial dehydrogenases (McCormack et al., 1990), 
elevation of mitochondrial matrix [Ca2+] enhances the formation of reduced pyridine nucleotides 
in rat (Pralong et al., 1992; Pralong et al., 1994) and human (Rohács et al., 1997; Spät et al., 
2012) glomerulosa cells. This effect contributes to the enhancement of aldosterone secretion in 
cells from both species (Spät et al., 2012; Wiederkehr et al., 2011).  
Although ACTH and angiotensin II act synergistically on aldosterone secretion (Spät and 
Hunyady, 2004), several laboratories reported that angiotensin II reduces basal and ACTH-
induced cAMP production (Bell et al., 1981; Marie and Jard, 1983; Woodcock and Johnston, 
1984; Begeot et al., 1987) (but see (Baukal et al., 1994; Burnay et al., 1998)). This inhibition has 
been attributed to the activation of the inhibitory G-protein, Gi (Enyedi et al., 1986; Hausdorff et 
al., 1987; Lu et al., 1996; Maturana et al., 1999; Rocco et al., 1990). The recent discovery in cell 
lines and rat cardiac myocytes that agonist - induced mitochondrial Ca2+ signals can increase the 
production of cAMP and ATP within the mitochondrial matrix (Di Benedetto et al., 2013) may 
offer an explanation for this apparent paradox. Indeed an increase of cAMP in a small 
compartment, e.g. mitochondria (that represent  25 % of the cytoplasmic volume in glomerulosa 
cells (Nussdorfer, 1980)), may be masked by the decrease of total intracellular cAMP caused by 
angiotensin II. Accordingly we decided to investigate whether mitochondrial cAMP, mt-cAMP, 
is modulated by angiotensin II-induced mitochondrial Ca2+ increases in adrenocortical cells and, 
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more decisively, if mt-cAMP can influence the secretion of steroid hormones. Here we take 
advantage of a fluorescent cAMP sensor selectively targeted to the mitochondrial matrix 
(4mtH30) and show that in an adrenocortical cell line, H295R cells (Bird et al., 1993; Rainey et 
al., 1994), not only angiotensin II - induced Ca2+ release from the endoplasmic reticulum results 
in a significant increase of mt-cAMP formation, but also that the mt-cAMP increase contributes 
to hormone production.  
 
 
2. Materials and methods 
 
2.1 Materials 
OPTI-MEM, Lipofectamine 2000, RNAiMax, Fluo-4 AM, Rhod-2 AM, SNARF AM and 
MitoTracker Deep Red were purchased from Life Technologies (Paisley, UK). siRNA for 
silencing sAC (MR2, (Di Benedetto et al., 2013)) and control siRNA (Universal Negative 
Control, SIC001) were obtained from Sigma-Aldrich (St. Louis, MO, USA). UltroSer G was 
from Bio Sepra (Cergy-Saint-Christophe, France). Coat-A-Count RIA kit was purchased from 
Siemens Health Care Diagnostic (Deerfield, IL).  
S100G cDNA, fused to a mitochondrial targeting sequence and cloned into an adenovirus 
vector under the control of the tetON promoter (mitoS100G) was prepared by Dr. A. Wiederkehr 
(Geneva, Switzerland). H30 was from K. Jalink’s lab (Ponsioen et al., 2004), 4mt-H30 and 
mtAlphi were constructed by the authors (G.D. & T.P.) as described (Cano Abad et al., 2004; Di 
Benedetto et al., 2013). 
Primary antibodies were purchased as follows: anti-soluble adenylyl cyclase (R21.002) was 
from CEP Biotech (Tamarac, FL), monoclonal anti--actin (A5316) was from Sigma-Aldrich, 
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anti-COX IV (sc-69359) was from Santa Cruz (Dallas, TX). The secondary antibody (goat anti-
mouse IgG horseradish peroxidase conjugate, R-05071-500) was purchased from Advansta 
(Menlo Park, CA). Other chemicals were obtained from Sigma-Aldrich.  
 
2.2 Cell culture and transfection 
H295R cells (CRL-2128, ATCC, Manassas, VA) were cultured in DMEM/Ham’s F12 (1:1 
v/v) containing 1% ITS+, 2% UltroSer G, 100 U/ml penicillin and 100 µg/ml streptomycin. One 
day before aldosterone experiments the concentration of Ultroser G was reduced to 0.5 %.  
Cells (2.5 - 4*104 H295R) were plated onto 25-mm diameter circular glass coverslips on day 
1. For FRET experiments the cells were transfected on day 2 with 3 g 4mtH30 or 1.6 g H30 
DNA (per coverslip) using Lipofectamine 2000 in OPTI-MEM. FRET measurements were 
performed on day 5 (4mtH30) or day 4 (H30). For silencing sAC, on day 3 the cells were 
transfected with 100 pmol MR2 siRNA or 100 pmol control RNA using lipofectamin RNAiMax 
in OPTI-MEM. The experiments were conducted on day 5. In Western blot studies cell lysis was 
performed 2 days after transfection with control or siRNA. For aldosterone measurements see 
subsection 2.7.  
In order to increase the Ca2+ buffering capacity in the mitochondrial matrix 3*104 cells were 
plated and infected 1 day later with Ad-mitoS100G (60 IFU/cell) together with 30 IFU/cell of 
Ad-tetON. Previous immunocytochemical examination using this protocol revealed the 
expression of S100G in 63% of the cells (Wiederkehr et al., 2011). 
 
2.3 Immunoblotting 
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Cell lysis, SDS-PAGE and immunoblotting were performed as described (Fülöp et al., 2011) 
with the following modifications. Cell lysis was performed with protease-completed RIPA buffer. 
PMSF was used at a concentration of 1 mM. 10 % SDS-PAGE was used.  
 
2.4 Confocal microscopy 
A Zeiss LSM710 confocal laser scanning microscope (operated with ZEN 11.0 software) and 
a 63*/1.3 oil immersion objective (Plan-Apochromat, Zeiss) were used. Subcellular localisation 
of the cAMP sensors (H30 or 4mt-H30) was examined in cells preloaded with MitoTracker Deep 
Red. Applying multitrack mode the YFP component of the sensor was excited at 514 nm, emitted 
light was measured between 520 and 595 nm whereas MTDR was excited at 633 nm and 
monitored at 640-740 nm. The images were deconvoluted using ImageJ 1.6.0.  
For monitoring cytosolic Ca2+ signals the cells were preloaded with Fluo-4, for recording 
mitochondrial pH changes the cells were transfected with mtAlphi. In both cases the applied 
excitation wavelength was 488 nm, the emitted light was monitored between 500-550 nm. For 
monitoring cytosolic pH the cells were preloaded with SNARF AM, the dye was excited at 488 
and the intensity of 612-699 nm emitted light was divided with that of the 560-600 nm light.  
The optical slices were 4 m in the cytosolic measurements and 1.5 m in the mitochondrial 
ones, respectively. As exception, H30 localisation examinations 0.8 or 1 µm optical slice was 
applied. Image acquisition frequency was 0.1 Hz. In all kinetic studies performed with confocal 
microscopy fluorescence intensity was normalized to the average 60-s intensity measured before 
stimulation (Fo).  
 
2.5 Measurements with fluorescent wide-field microscopy 
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cAMP level in the mitochondrial matrix and in the cytosol were monitored using 4mt-H30 
and H30, respectively. These measurements as well as those of mitochondrial [Ca2+] were 
performed on an inverted microscope (Axio Observer D1, Zeiss) equipped with a 40x1.4 Plan-
Apochromat oil immersion objective (Zeiss) and a Cascade II camera (Photometrics). Excitation 
wavelengths were set by a random access monochromator connected to a xenon arc lamp 
(DeltaRAM, Photon Technology International). For ratiometric measurements of H30 or 4mt-
H30 excitation wavelength of 435 nm was selected along with a Dual-View emission splitting 
system (505dcxr, 480/30 and 535/30; Photometrics) enabling the acquisition of simultaneous 
donor (eCFP) and acceptor (eYFP) emission. The ratio 535/480 signals were evaluated with 
Metamorph Offline Version 7.7.0.0. 
Since binding of cAMP to the sensor reduces FRET efficiency, an increase in cAMP 
concentration results in a decrease of 535nm emission and an increase in 480nm emission 
intensities. Accordingly, in order to express the cAMP increases vs time as an upward, rather 
than a downward deflection, the increase in cAMP level was computed as 100 * (Ro - R)/ Ro and 
expressed as ΔR/Ro (%), where R is the ratio of background-subtracted fluorescence intensities at 
535 nm and 480 nm at any time in the experiment and Ro the mean 535/480 nm ratio of the 100 
sec period prior to stimulation.With regard to the often unstable baseline, the 4mtH30 signal was 
regarded as increased cAMP level if the integrated ΔR/Ro (%) within at least a 100 sec period 
during the 5 min post-stimulation period was significantly greater (p < 0.05) than that within a 
similar period preceding the stimulation.  
Rhod-2 excitation wavelength was 550 nm. The emitted light passed through a 570-nm 
dichroic mirror and was measured with a 610/50 filter. The expressed fluorescence emission 
values (F) were normalized to the mean F value of the 100-sec period prior to stimulation.  
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2.6 Superfusion 
Microscopic experiments were carried at room temperature. Following a preincubation for 30 
min (in the absence or presence of any inhibitor) the coverslips were superfused with a modified 
Krebs-Ringer solution containing 140 mM Na+, 4.5 mM K+, 1.2 mM Ca2+, 0.5 mM Mg2+, 5 mM 
Hepes and 2 mM HCO3
 (pH 7.4). The flow rate was ~ 1ml/min. The solutions were applied with 
a solenoid valve-equipped, gravity-driven superfusion system, terminating at ~2 mm from the 
selected cells.  
 
 
 
2.7 Aldosterone production  
Cells (150 - 300 thousand/well) were plated in a 24-well culture dish (day 1). On day 3 the 
UltroSer G content of the culture medium was reduced to 0.1 %. On day 4, after a 30-min 
preincubation in serum-free medium that contained 2-OHE or solvent, the cells were incubated at 
37o for 2 hours in a similar medium, with or without angiotensin II. When the cells were 
transfected with control or siRNA on day 2, UltroSer G content was reduced on day 4 and final 
incubation, as detailed above, took place in day 5. 
Aldosterone and protein content of the supernatant were determined with Coat-A-Count RIA 
kit and Bradford assay, respectively.  
 
2.8 Statistics 
Means + S.E.M. are used. With the exception of cytosolic pH measurements all the 
experiments were performed on cells derived from at least two different cell passages. For 
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estimating significance of differences, Student’s unpaired t-test, sign test, chi-square test or 
factorial ANOVA was used, as appropriate. Data were analyzed with Statistica 9. 
 
 
 
3. Results 
 
3.1 Expression of soluble adenylyl cyclase in H295R cells 
A specific antibody against sAC (Zippin et al., 2003) revealed an approximately 50 kDa 
protein band in Western-blots of total lysates from both HeLa and H295R cells. When comparing 
samples of identical protein mass, the average density of the sAC band in H295R cells attained 
60 + 9 % of that in HeLa cells (n=5). Two days after transfecting H295R cells with a specific 
siRNA (MR2, (Di Benedetto et al., 2013)) the density of the sAC band (related to that of -actin) 
was 74 + 18 % that of control siRNA-transfected cells (n=3, Fig. 1A). After permeabilizing the 
cells with digitonin (25 µg/ml, 5 min, 4oC) the majority of immunoreactive sAC (related to the 
mitochondrial marker COX-IV) remained in the particulate fraction (n=3, data not shown). 
Altogether, these data are compatible with the conclusion that the majority of sAC in H295R 
cells, similarly to COS-1 cells (Acin-Perez et al., 2009b) is not cytosolic, but it is localized in 
membrane bound organelles, most likely the mitochondria . 
 
3.2 Mitochondrial cAMP as measured with 4mtH30 in H295R cells 
The cAMP sensor 4mtH30 consists of 4 copies of human COX VIII targeting sequence fused 
to the N-terminus of the cAMP sensor H30. The latter contains, between ECFP and EYFP, the 
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whole Epac1 protein, rendered catalytically inactive with two mutations in the Rap1 binding 
domain and deprived of the membrane-targeting DEP domain (Ponsioen et al., 2004). Confocal 
microscopy revealed that in H295R cells, 3 days after transfection, 4mtH30 shows, as previously 
described in other cells, an excellent colocalization with the classical mitochondrial marker 
Mitotracker Deep Red (Pearson coefficient: 0.863 + 0.054, n=6; Fig.1B). 
Cyclic AMP binding to H30/4mtH30 reduces the efficiency of FRET between CFP and YFP, 
therefore elevation of cAMP concentration causes a decrease in the ratio, R, between the 
fluorescence emitted at 535 nm (YFP) and that emitted at 480 nm (CFP), shown on Figures as 
ΔR/R0 x 100. R0 is the average R of a 100s control interval. Superfusion with control medium for 
450 seconds did not evoke any significant change in the FRET signal (n = 25, Fig. 2B). 
To test whether intramitochondrial cAMP level can be modulated by activation of matrix 
sAC, H295R cells transfected with 4mtH30, were superfused with an isosmotic medium 
containing 50 mM HCO3
- (as sAC is known to be activated by bicarbonate ions (Buck et al., 
1999; Jaiswal and Conti, 2003; Litvin et al., 2003; Steegborn et al., 2005b)). An increase in the 
ΔR/R0 was observed in 75 % of the examined 20 cells (Fig. 2A). Noteworthy, in parallel, the 
measurement of matrix pH with mtAlphi (Cano Abad et al., 2004) revealed a net alkalinisation 
upon HCO3
- addition (n=20, Fig. 2C). Given that pH alkalinization results in an increase of YFP 
fluorescence (Di Benedetto et al., 2013), the total rise of mt-cAMP may be underestimated.  
The data presented in the section showed that the cAMP sensor 4mtH30 was appropriately 
targeted to the mitochondrial matrix (as previously described (Di Benedetto et al., 2013)) and 
responded in the expected way to bicarbonate, applied as positive control. 
 
3.3 Effect of angiotensin II on mitochondrial cAMP formation 
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In preliminary experiments we examined the effect of 1 and 10 nM angiotensin II on the level 
of mt-cAMP. The effect of 1 nM was recorded in 133 cells. A cell was regarded responsive in 
terms of cAMP response if the integrated R/R0 value within at least a 100-sec period during the 
5-min post-stimulation period was significantly greater (p < 0.05) than that within a similar 
period preceding the stimulation. Elevation of mt-cAMP was observed in 40 %, whereas a small 
decrease of the mt-cAMP signal was detected in 6 % of cases (p < 0.01).  
In the next series of experiments we studied the effects of 10 nM angiotensin II. First 
angiotensin - induced changes in cytosolic (Fluo-4) and mitochondrial (Rhod-2) [Ca2+] were 
measured in the same cells. At the single cell level the cytosolic Ca2+ signals were variable in 
amplitude and kinetics, yet they were faithfully transferred to the mitochondrial matrix in all cells 
(Supplementary Fig. 1). Examining altogether 52 cells the peptide brought about a mt-cAMP 
elevation in 73 % of the cells (these cells are termed responsive cell, see previous paragraph). In 
spite of the heterogeneity between individual responses (Supplementary Fig. 2), the averaged 
curve of responsive cells (Fig. 3A) convincingly displayed a mitochondrial response. The average 
ΔR/Ro of a 100-sec period (showing the highest cAMP signal) increased by 2.28 + 0.23 % as 
compared with that of the 100 s pre-stimulation period (n=34). (Due to a decreasing ratio during 
the control period the response could not be quantified in 4 cells). A negative response was 
observed in 8 % (increase vs. decrease: p < 0.0001, Fig. 3C) and the not responding were the 
remaining 19 % of the cells (Fig. 3B). Given that the percentage of responding cells in the 10 nM 
angiotensin II group was significantly higher than in the 1 nM group (p = 0.0001), in subsequent 
experiments we focused on the effects of 10 nM angiotensin II.  
Considering the variability of cAMP rises in different cells and different preparations both in 
terms of amplitude and kinetics, a significant parameter to compare different conditions appeared 
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to be the percentage of responsive cells. This parameter was, unless otherwise indicated, used in 
evaluating the following experiments. In order to inhibit sAC cells stimulated with 10 nM 
angiotensin II, were exposed to the sAC inhibitor 2-OHE (20 M) (Steegborn et al., 2005a). The 
inhibitor was present also during a 30-min preincubation. Supplementary Fig. 3 demonstrates that 
the drug did not modify either the cytosolic or mitochondrial Ca2+ response to angiotensin II; 
however, at the same dose, it reduced the percentage of cells showing a mt-cAMP increase to 
angiotensin II by 34 % (p = 0.0135, Fig. 4A). The specificity of the inhibitor was confirmed by 
transfecting the cells 2 days earlier with MR2, a specific siRNA for the sAC gene. In this case the 
percentage of responding cells decreased by 67 % (p = 0.006, Fig. 4B). Di Benedetto et al. (2013) 
showed that a generic inhibitor of phosphodiesterases PDE, such as IBMX, or a PDE2A specific 
blocker, increase mt-cAMP level in response to stimulation. We thus examined the effect of the 
PDE2A inhibitor EHNA (erythro-9-(2-hydroxyl-3-nonyl)adenine (Acin-Perez et al., 2011)) on 
angiotensin II – induced changes in mt-cAMP. EHNA also added to the preincubating medium, 
evoked no significant change in the percentage of responsive cells, but the peak amplitude of the 
response was significantly higher in the presence of 10 µM EHNA (p = 0.007, Fig. 4D). 
In order to confirm that angiotensin II - induced mt-cAMP response was induced by increased 
mitochondrial [Ca2+], the peak increases in matrix Ca2+ were attenuated with heterologously 
expressed mitoS100G, a mitochondria-targeted Ca2+ binding protein under the control of 
doxycycline (DOX) - inducible tetOn promoter (Wiederkehr et al., 2011). We previously 
demonstrated that expression of mitoS100G results in a significant reduction in the amplitude of 
the mitochondrial Ca2+ increases. In DOX-negative control cells 9 out of 14 cells showed an 
angiotensin II - induced mt-cAMP increase, whereas only 3 out of 12 cells showed a similar 
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response after DOX-dependent infection. The difference between the two groups was significant 
(p = 0.045, Fig. 4C). 
The data in this section thus show that the mitochondrial sAC can be activated by angiotensin 
II in a concentration-dependent way. Pharmacological inhibition and silencing of sAC, as well as 
Ca2+ buffering in the mitochondrial matrix, reduce the effect of angiotensin II whereas inhibition 
of the mitochondrial cAMP phosphodiesterase enhances the angiotensin-induced rise of mt-
cAMP. 
 
3.4 Role of mitochondrial cAMP in the control of aldosterone production 
 
We next investigated whether mt-cAMP plays any role in steroid hormone secretion, the 
specific function of adrenocortical cells. H295R cells were exposed for 2 hours to angiotensin II, 
applied at maximal (1 nM) or supramaximal concentration (10 nM) and their aldosterone 
production was measured. Angiotensin II evoked a mean 2.7 fold increase in aldosterone 
secretion whereas the increase in 2-OHE treated cells was reduced to 1.5 fold on average (Fig. 
5A). Statistical analysis after pooling the 1 and 10 nM data showed that the effect of 2-OHE was 
highly significant (p = 1 x 10-6) and, more importantly, the negative interaction of the agonist and 
the enzyme inhibitor was also highly significant (p = 1 x 10-6). 
The observation obtained with pharmacological inhibition of sAC has been confirmed by 
transfection with siRNA. The 2-hour hormone production was examined 3 days after transfection 
with 0. As shown in Fig. 5B aldosterone secretion in siRNA-transfected cells was significantly 
smaller than in control RNA-transfected cells (p = 0.002) and, more importantly, the extent of 
stimulation was reduced from an average of 1.61 to 1.47, reflecting a significant negative 
interaction of gene silencing with the agonist (p = 0.041). 
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sAc is localized both in the cytosol (Braun and Dods, 1975; Jaiswal and Conti, 2001) and in 
the mitochondrial matrix (Acin-Perez et al., 2009a). The question then arises as to whether the 
effects of sAC inhibition on aldosterone production depends on mt-sAC or cytosolic sAC or both. 
In order to distinguish among these possibilities cells were transfected with H30, the cytosolic 
version of the cAMP sensor. The probe, as expected, was selectively localized in the cytosol and 
excluded from mitochondria (Fig. 6A and B). 10 nM angiotensin II induced a clear cytosolic 
cAMP rise in 16 out of 22 cells (Fig. 6C) in controls, the average ΔR/Ro of a 100-sec stimulation 
period in the responding control cells showed a 3.93 + 0.45 % increase. The sAC inhibitor 2-
OHE failed to influence this cytosolic cAMP response: 75  % of 2-OHE-treated cells responded 
to angiotensin with cAMP signal, the average ΔR/Ro showed a 3.85 + 0.35 % increase (Fig. 6D).  
This observation demonstrates that angiotensin II is capable of increasing cytosolic cAMP 
level by activating a 2-OHE insensitive AC. In addition, superfusion with 50 mM bicarbonate 
(that induces an increase in mt-cAMP) is associated with a drop in ΔR/Ro in the cytosol in 75 % 
of the cells (n = 16, Fig. 6E). This drop is probably only apparent as bicarbonate induces an 
alkalinization of cytosolic pH, similar in amplitude to that caused in the mitochondrial matrix 
(not shown). We thus conclude that in H295R cells: i) the activity of sAC in the cytosol is 
negligible and ii) inhibition of angiotensin II-induced aldosterone production by 2-OHE depends 
on its inhibition of mitochondrial sAC. 
Summarizing the data in this section, basal and angiotensin II-stimulated aldosterone 
secretion was reduced by inhibiting or silencing sAC. The activity of sAC in the cytosol is 
negligible, but the cytosolic Ca2+ increase elicited by angiotensin II can activate transmembrane 
adenylyl cyclase(s).  
 
4. Discussion  
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The recent discovery of the existence of an autonomous intramitochondrial cAMP signaling 
machinery (composed by a sAC isoform and a cAMP degrading mechanism sensitive to both 
IBMX and EHNA, a PDE2 specific inhibitor (Acin-Perez et al., 2009b)) has been followed by the 
direct demonstration that in HeLa and CHO cells as well as in rat cardiomyocytes a rise in cAMP 
can be triggered by an increase in HCO3
- and Ca2+ in the matrix, acting synergically (Di 
Benedetto et al., 2013). Intramitochondrial cAMP rise is paralleled by a significant increase of 
the matrix level of ATP. On the contrary, no consensus exists as to the target(s) of cAMP in the 
mitochondrial matrix (see for example (Acin-Perez et al., 2009b; Di Benedetto et al., 2013; 
Lefkimmiatis et al., 2013)). Moreover, and most importantly, the possible functional effects of 
this cAMP increase are still largely unexplored.  
In the present paper we have investigated whether the matrix cAMP signaling toolkit is 
expressed also in other differentiated cell types and whether functions other than ATP production 
can be modulated by the cAMP concentration in the matrix. To this end we used an 
adrenocortical cell line, H295R cells, a model system widely employed to investigate the function 
of glomerulosa cell, especially the agonist dependent production of aldosterone (Bird et al., 1993; 
Rainey et al., 1994). For estimating mt-cAMP formation we employed the FRET-based sensor 
4mtH30 (Di Benedetto et al., 2013). This sensor, as other probes of the same family, undergoes a 
change (reduction) of FRET upon increases in the local cAMP level. However other factors, e.g., 
differential photobleaching of CFP and YFP fluorescence or pH changes may lead to apparent, 
artifactual, changes in mt-cAMP. These problems were directly addressed in the present 
experiments and in the study of Di Benedetto et al. (2013). In particular, as far as photobleaching 
is concerned, superfusion with control medium for 450 s (the maximal duration of the treatments 
with drugs or agonists) failed to exert any significant influence on the FRET signal. As to pH 
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effects, neither 2-OHE or EHNA cause any change of matrix pH (Di Benedetto et al., 2013). 
Last, but not least, all the treatments used (sAC inhibitor 2-OHE, siRNA against sAC or the 
phosphodiesterase inhibitor EHNA) modified mt-cAMP in the expected direction, giving 
concordant results. More specifically, we here demonstrate that: i) angiotensin II, an agonist 
known to induce (often oscillatory) increases in cytosolic and mitochondrial Ca2+ (Brandenburger 
et al., 1996; Lalevee et al., 2003; Spät and Hunyady, 2004; Spät and Pitter, 2004), as well as 
reduction in pyridine nucleotides (Pralong et al., 1992; Pralong et al., 1994; Rohács et al., 1997), 
also causes a dose dependent rise in mt-cAMP; ii) the effects of angiotensin II on mt-cAMP are 
reduced by buffering matrix Ca2+ increases caused by the expression of mitoS100G (Wiederkehr 
et al., 2011), by siRNA reduction in sAC expression or by the sAC inhibitor 2-OHE and are 
augmented by the PDE2A inhibitor EHNA; iii) a clear increase in mt-cAMP is also caused by the 
well known sAC activator, bicarbonate (Buck et al., 1999; Jaiswal and Conti, 2003; Litvin et al., 
2003; Steegborn et al., 2005b). Three lines of evidence support the conclusion that sAC is 
primarily localized in the mitochondria: i) the majority of the protein band (molecular weight 50 
kDa), revealed in lysates of H295R cells by immunoblotting with anti-sAC antibodies and 
corresponding to the truncated, fully active form of sAC (Buck et al., 1999), remained in the 
pellet after plasma membrane permeabilization with digitonin; ii) the mitochondrial cAMP sensor 
4mtH30 and the cytosolic sensor H30 responded with opposite signals to bicarbonate addition, 
i.e. a rise with 4mtH30 and a small drop with H30, though bicarbonate caused an alkalinization in 
both compartments; iii) the sAC inhibitor 2-OHE added together with angiotensin II, attenuated 
the mt-cAMP signal, but had no effect on the cytosolic cAMP rise caused by the stimulus.  
The final key question concerns the functional significance of the mt-cAMP formation. In 
order to address this point we investigated the effect of manipulating mt-cAMP on the primary 
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biological function of adrenocortical cells, namely hormone production. The stimulation of 
aldosterone production by the cAMP rise induced by ACTH addition and the role of angiotensin 
II (or K+) dependent rise in cytosolic Ca2+ on hormone production (and the potentiation of 
cytosolic Ca2+ - evoked aldosterone production (Wiederkehr et al., 2011) by mitochondrial Ca2+ 
rises) are firmly established facts. On the contrary, the crosstalk between the Ca2+ and cAMP 
signaling systems has been thoroughly investigated in the past, but conflicting results have been 
reported. The Tait group showed a K+-evoked increase in cAMP formation in rat glomerulosa 
cells (Hyatt et al., 1986). Several years later, the Ca2+-activatable isoform 1 of adenylyl cyclase 
(AC1) was shown to be expressed in human glomerulosa and fasciculata cells (Cote et al., 2001) 
whereas another isoform (AC3), possibly also activated by Ca2+, was found in human (Cote et al., 
2001), rat (Nishimoto et al., 2013) and bovine (Burnay et al., 1998) glomerulosa cells. On the 
contrary, a reduced cAMP formation was reported in angiotensin II – stimulated rat glomerulosa 
(Bell et al., 1981; Woodcock and Johnston, 1984) or bovine adrenocortical cells (Begeot et al., 
1988; Marie and Jard, 1983). In our hands, in H295R cells, angiotensin II caused a clear and 
reproducible increase in cytosolic cAMP. Whether this rise of cAMP depends on Ca2+ dependent 
activation of AC remains to be established. It is not easy to reconcile these apparently 
contradictory findings. It may be proposed that coexpression of different amounts of Ca2+-
activated and Ca2+-inhibited isoforms (AC5 and AC6, (human: (Cote et al., 2001), rat: (Shen et 
al., 1997)) is a species (or cell) specific feature and may account for the different results obtained 
in different models. Despite these contradictions on the relationships between angiotensin II 
stimulation and cAMP levels, a consensus exists on the synergic actions of cytosolic cAMP 
produced by ACTH and Ca2+ rises on aldosterone production (Spät and Hunyady, 2004).  
The evidence presented here, i.e. a reduction in hormone secretion in angiotensin II stimulated 
cells by conditions that reduce the rise in mt-cAMP levels without affecting cytosolic Ca2+, 
You created this PDF from an application that is not licensed to print to novaPDF printer (http://www.novapdf.com)
18 
 
suggests that, similarly to what occurring for the cysosolic compartment, the mt-cAMP rise 
synergizes with intramitochondrial Ca2+ in regulating aldosterone biosynthesis. The specific 
molecular target of mt-cAMP, however, remains to be established (Lefkimmiatis et al., 2013).  
 Summarizing the present observations, in addition to a possible activation of a 
transmembrane AC by the cytosolic Ca2+ signal, also a mitochondrial AC, the soluble sAC, is 
activated by mitochondrial Ca2+ increases. Activation of sAC and thus of mt-cAMP, enhances the 
Ca2+ - induced production of aldosterone, a hormone controlling not only salt-water balance, but 
also playing a significant role in the control of blood pressure and in the progress of various 
cardiovascular, renal and inflammatory diseases (Andersen, 2013; Briet and Schiffrin, 2010; 
Gomez-Sanchez, 2014; Tomaschitz et al., 2010). These data provide the first evidence that cAMP 
rise in mitochondria has not only a general bioenergetics function (stimulation of ATP production 
(Acin-Perez et al., 2009b; Di Benedetto et al., 2013)), but also a cell specific role, such as the 
production of the glomerulosa cell hormone, aldosterone.  
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Legend of Figures        
 
Fig. 1 Expression of soluble adenylyl cyclase and its sensor 4mt-H30 in mitochondria of H295 
cells. (A) Representative Western blot of sAC expression in H295R cells, transfected with control 
siRNA or siRNA for sAC (MR2). β-actin was used as loading control. HeLa cells served as 
positive control for sAC. For comparing expression in the two cell types protein content of the 
samples is indicated above the lanes. (B) Mitochondrial localisation of 4mt-H30 in an H295R 
cell. Cells were transfected with 4mt-H30 (shown in green) three days earlier and loaded with 
MitoTracker Deep Red (MTDR, shown in red) before the confocal microscopy. Colocalisation is 
indicated in the merged image (left bottom) in yellow. The optical slice was 1.5 µm. The result of 
line scanning in the merged image is shown in the right bottom panel. 
 
Fig. 2 Effect of bicarbonate on mitochondrial cAMP formation. (A) Effect of superfusion with 
50 mM bicarbonate on mt-cAMP was recorded with 4mt-H30. Out of 20 examined cells the 
averaged response curve is shown for 16 cells in which the integrated fluorescence intensity 
within at least a 100-sec period during the 5-min post-stimulation period was significantly greater 
(p < 0.05) than within a similar period preceding the stimulation. The increase in cAMP was  
computed as 100 * (Ro - R)/ Ro and expressed as ΔR/Ro (%) where R was the ratio of 
fluorescence intensity of raw FRET (emission at 535 nm) and eCFP (480 nm), Ro was the mean 
ratio of the 100-sec period prior to stimulation. Means + are shown.  (B) Superfusion with control 
medium does not induce any significant change in the mitochondrial cAMP level. Averaged 
curve for 25 cells, superfused for 450 seconds. Means + S.E.M. are shown. (C) Effect of 
bicarbonate (50 mM) and subsequent acetate (30 mM) superfusion on mitochondrial pH, 
monitored with mtAlphi. Upward deflection indicates increased pH. 
 
Fig. 3 Effect of superfusion with 10 nM angiotensin II on mitochondrial cAMP formation as 
recorded with 4mt-H30. The effect of the peptide was examined in 52 cells. (A) Averaged 
response curve is shown for 34 responsive cells in which the integrated fluorescence intensity 
within at least a 100-sec period during the 5-min post-stimulation period was significantly greater 
(p < 0.05) than within a similar period preceding the stimulation. (Due to a decreasing ratio 
during the control period no response could be calculated in 4 further cells.) (B) Averaged curve 
of the mt-cAMP signal of 10 non-responsive cells. (C) Averaged curve of the mt-cAMP signal of 
4 cells showing inverse signal. Means + are shown. 
 
Fig. 4 Modification of angiotensin II – induced mitochondrial cAMP formation. The cells were 
(A) exposed to 20 µM 2-OH-estradiol (2-OHE), (B) with control siRNA or MR2, a specific 
siRNA for sAC, (C) infected with mitoS100G, a mitochondria-targeted Ca2+ binding protein or 
(D) exposed to 10 µM EHNA, an inhibitor of the mitochondrial phosphodiesterase PDE2A. 
Percentage of cells displaying increased cAMP formation (red), no change (green) or reverse 
response (blue) is shown. In panels A, B and C the number of cells is shown within the columns. 
Peak amplitude (means + S.E.M.) of mt-cAMP-response in control or EHNA-treated cells is 
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shown in panel D (number of cells is shown within the columns). The following significances 
were calculated: (A) 2-OHE: p = 0.0135, (B) MR2: p = 0.006, (C) mitoS100G: p = 0.045, (D) 
EHNA: p = 0.007. 
 
Fig. 5 Reduced activity of sAC and aldosterone secretion.  (A)  Effect of 20 µM 2-OHE on 
angiotensin II (1 or 10 nM) – induced aldosterone production. The effect of 2-OHE on hormone 
production as well as the negative interaction between the agonist and the enzyme inhibitor were 
significant (p = 1 x 10-6). (B) Effect of siRNA (MR2) against sAC on aldosterone secretion 
stimulated with 10 nM angiotensin II. Examination of aldosterone secretion was performed 3 
days after gene silencing. Both the reduction of hormone secretion by siRNA (p = 0.002) and the 
negative interaction between angiotensin II and siRNA were significant (p = 0,041). 
(Significance was estimated with factorial ANOVA.) 
 
Fig. 6  Effect of angiotensin II (10 nM) on cAMP formation in cytosol. (A) Location of cytosolic 
cAMP sensor H30 was examined with confocal microscopy 2 days after transfection. Image in 
the YFP channel is shown. The optical layer was 0.8 µm. The arrows show H30-free 
mitochondria. (B) The merged image of the YFP channel (panel A) and the MitoTracker Deep 
Red (MTDR) channel is shown. Colocalization of H30 and MTDR would appear in yellow. (C)  
Angiotensin II (10 nM) – induced cytosolic cAMP formation. Representative for 16 (out of 22) 
cells. (D) Angiotensin II – induced cytosolic cAMP formation in the presence of 20 µM 2-OHE. 
Representative for 12 (out of 16) cells. (E) Effect of bicarbonate (50 mM) superfusion on 
apparent cAMP level, measured with H30  Representative for 7 cells. 
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Supplementary Fig. 1 Heterogeneity of angiotensin II – induced Ca2+ signalling. H295R cells 
were superfused with 10 nM angiotensin II. Cytosolic and mitochondrial [Ca2+], recorded with 
Fluo-4 and Rhod-2, respectively, are shown in three separate cells, representating 18 cells. 
Fluorescence intensity values (F) were normalized to the control period values (Fo).   
 
Supplementary Fig. 2  Heterogeneity of the mitochondrial cAMP response to angiotensin II.   
The response to 10 nM angiotensin II, recorded with 4mt-H30, is shown in three separate cells. 
The increase in cAMP was  computed as 100 * (Ro - R)/ Ro and expressed as ΔR/Ro (%) where R 
was the ratio of fluorescence intensity of raw FRET (emission at 535 nm) and eCFP (480 nm), Ro 
was the mean ratio of the 100-sec period prior to stimulation. 
 
Supplementary Fig. 3  Effect of the sAC inhibitor drug 2-OH-estradiol (2-OHE, 20 µM) on 
angiotensin II (10 nM) - induced cytosolic and mitochondrial Ca2+ signaling. Cytosolic [Ca2+] 
was monitored in Fluo-4 loaded cells with confocal microscopy, mitochondrial [Ca2+] was 
recorded in Rhod-2 loaded cells with fluorescent wide-field microscopy. Each panel shows the 
response of 3 representative cells. The effect of 2-OHE was not statistically significant.  
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